help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vinter-Jensen, L.
Right arrow Articles by Nexo, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vinter-Jensen, L.
Right arrow Articles by Nexo, E.

American Journal of Pathology, Vol 147, 1330-1338, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates

L Vinter-Jensen, CO Juhl, JC Djurhuus, SS Poulsen, EZ Dajani, KD Brown, TF Orntoft, PS Teglbjaerg and E Nexo
Department of Clinical Biochemistry, Aarhus University Hospital, Denmark.

Epidermal growth factor (EGF) is present in large amounts in the urine, but the effects of systemically administered EGF on the urinary tract have not been described previously. In the present paper, we describe a potent growth induction of EGF on the urinary tract. Goettingen minipigs were treated with solvent (n = 5), EGF 30 micrograms/kg/day (n = 6) for 4 weeks, or EGF 30 micrograms/kg/day for 5 weeks followed by 3 weeks of recovery (n = 5). The ureters and bladders were examined by routine histology and electron microscopy and were immunostained for proliferating cell nuclear antigen. Four weeks of EGF treatment increased the median cross sectional area of the ureter fourfold with growth of all wall layers. The urothelium was widened from 5 cell layers in the controls to 10 in the EGF-treated animals. Proliferating cell nuclear antigen immunostaining revealed an increased mitotic activity in the basal zone of the urothelium. In the luminal zone, glycoconjugates accumulated in goblet cells, in cells with intracytoplasmic lumina, and beneath the luminal cell membrane in the umbrella cells. Our studies present a new experimental approach to growth induction of the urinary tract. The findings implicate the EGF system in regulating urothelial growth and glycoconjugate biosynthesis.


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
L. Finzi, V. Barbu, P.-R. Burgel, M. Mergey, K. S. Kirkwood, E. C. Wick, J.-Y. Scoazec, F. Peschaud, F. Paye, J. A. Nadel, et al.
MUC5AC, a Gel-Forming Mucin Accumulating in Gallstone Disease, Is Overproduced via an Epidermal Growth Factor Receptor Pathway in the Human Gallbladder
Am. J. Pathol., December 1, 2006; 169(6): 2031 - 2041.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. TAKEYAMA, J. V. FAHY, and J. A. NADEL
Relationship of Epidermal Growth Factor Receptors to Goblet Cell Production in Human Bronchi
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 511 - 516.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Takeyama, K. Dabbagh, H.-M. Lee, C. Agusti, J. A. Lausier, I. F. Ueki, K. M. Grattan, and J. A. Nadel
Epidermal growth factor system regulates mucin production in airways
PNAS, March 16, 1999; 96(6): 3081 - 3086.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.